Letter: is it appropriate to use a fatty liver index >60 as an alternative criterion for non-alcoholic fatty liver disease? Authors' reply.
Saved in:
| Title: | Letter: is it appropriate to use a fatty liver index >60 as an alternative criterion for non-alcoholic fatty liver disease? Authors' reply. |
|---|---|
| Authors: | Rivera-Andrade A; Institute of Nutrition of Central America and Panama (INCAP) Research Center for the Prevention of Chronic Diseases, Institute of Nutrition of Central America and Panama, Guatemala City, Guatemala., Petrick JL; Slone Epidemiology Center, Boston University, Boston, Massachusetts, USA., Alvarez CS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Graubard BI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Florio AA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.; Department of Nutrition, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA., Kroker-Lobos MF; Institute of Nutrition of Central America and Panama (INCAP) Research Center for the Prevention of Chronic Diseases, Institute of Nutrition of Central America and Panama, Guatemala City, Guatemala., Parisi D; Information Management Services, Colesville, Maryland, USA., Freedman ND; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA., Lazo M; Department of General Internal Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA., Guallar E; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA., Groopman JD; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.; Department of Environmental Health and Engineering, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA., Ramirez-Zea M; Institute of Nutrition of Central America and Panama (INCAP) Research Center for the Prevention of Chronic Diseases, Institute of Nutrition of Central America and Panama, Guatemala City, Guatemala., McGlynn KA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA. |
| Source: | Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Jul; Vol. 56 (2), pp. 378-379. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
